Jen-Hsun Huang, President and Chief Executive Officer of Nvidia Corp., speaks during the company's event at Mobile World Congress Americas in Los Angeles on October 21, 2019.
Patrick T. Fallon | Bloomberg | Getty Images
Check out the companies making headlines after Thursday's bell:
GenMark Diagnostics – GenMark shares rose more than 4% after the Food and Drug Administration gave the company emergency clearance to run a test that checks for flu, Covid-19, and other viruses.
Exelon – The nuclear power producer's shares rose more than 1% in after-hours trading after activist investor Keith Meister classified the stock as an investment idea. Meister said during a presentation that Exelon had "significant" upside potential.
Nvidia – Nvidia shares fell 0.7% after a New Street Research analyst downgraded the chip maker to sell from neutral. The analyst pointed to a possible slowdown in PC consumer spending as well as "motherboard manufacturers and GPU board partners cutting orders".
Zoom Video – Zoom Up 0.5% Mizuho launched coverage on the stock with a buy rating and a target price of $ 550. The company can continue to generate oversized revenue growth due to its position as a leader, global recognition, and cross-selling opportunities and its position in a growing and depressed long-tail market. "The analyst's price target implies a 12 month uptrend of $ 15 from Thursday's close of $ 478.55 per share.
NXP Semiconductor – NXP Semiconductor's shares rose more than 5% after the company released a higher-than-forecast third-quarter revenue forecast. NXP expects third-quarter sales of approximately $ 2.267 billion. Analysts polled by FactSet had forecast sales of $ 2.01 billion.
– CNBC's Michael Bloom contributed to this report.